Cancer must be a health priority in 2022

Carla Lockhart MP • January 4, 2022

DUP MP Carla Lockhart has written to Health Minister Robin Swann MLA to press for cancer care to take greater priority in 2022, with a focus on addressing aspects of care impacted by the pandemic.

Carla Lockhart said:

“Since the start of the pandemic, the impact on cancer care has been significant. Diagnosis of cancer has been missed or delayed due to a reduction and restriction on services. This has led to prognosis being impacted on, and sadly some have lost their lives due to this.

Similarly, there are many people across Northern Ireland who have had cancer operations – even red flag procedures – cancelled at short notice. This is devastating to the patient and their loved ones and of course also can impact on their prognosis.

We need to see 2022 as a year when catch up within cancer care is a health focus. Whilst COVID will remain with us, we simply cannot put cancer patients and cancer care behind COVID in the queue for care. If we do, lives will be lost that could have otherwise been saved. That is the stark reality.

Over the Christmas period I have had several families contact me concerning appointments they are waiting on for cancer treatment/diagnosis. This is just unacceptable and needs addressed.

I hope the Health Minister will work to protect and enhance the cancer care provision over this coming year. This will require investment, and ministerial direction. I hope this will be seen in 2022 and that cancer patients will be prioritised as they ought to be.”

< Older Post

Newer Post >

Upper Bann MP Carla Lockhart expresses bitter disappointment at failure to add MLD to newborn heel-prick screening

By Carla Lockhart MP • January 9, 2026

Upper Bann MP Carla Lockhart has spoken of her bitter disappointment following confirmation that Metachromatic Leukodystrophy (MLD) will not be added to the routine newborn heel-prick screening programme, despite sustained campaigning and evidence that the condition can be treated if identified at birth.

MP welcomes DAERA support for BTV movement testing within control zones

By Carla Lockhart MP • January 8, 2026

Confirmation that DAERA will absorb laboratory costs associated with the mandatory pre-movement testing of animals in the designated Bluetongue Temporary Control Zone, has been welcomed by Carla Lockhart MP.

£2.5m inheritance tax threshold a hard-won concession, but remains insufficient

By Carla Lockhart MP • January 8, 2026

Upper Bann MP Carla Lockhart has described the Labour government’s increased inheritance tax threshold on agricultural and business property relief as a hard-won and welcome concession, but says it remains insufficient.

New Year Message to the People of Upper Bann

By Carla Lockhart MP • January 7, 2026

As we enter a new year, Upper Bann MP Carla Lockhart has reflected on the challenges of the past 12 months while setting out her priorities for 2026, reaffirming her commitment to serving constituents across the area.

Lockhart Shows Support for Morning Buzz Coffee

By Carla Lockhart MP • January 6, 2026

Upper Bann MP Carla Lockhart has welcomed a new local business venture after visiting Morning Buzz Coffee, praising the commitment and initiative behind a one-man operation serving the local community.

Rural Roads Must Be Taken Seriously During Severe Winter Weather

By Carla Lockhart MP • January 6, 2026

Upper Bann MP Carla Lockhart has raised serious concerns about the safety of rural roads during the current spell of severe winter weather, following a recent bus incident at Esky and ongoing engagement with Roads Service officials on gritting arrangements, grit salt availability and the treatment of rural routes across the constituency.

Upper Bann MP Carla Lockhart Raises Serious Concerns Over Delays to Red Flag Breast Appointments

By Carla Lockhart MP • January 6, 2026

Upper Bann MP Carla Lockhart has raised serious concerns over significant delays facing women referred to breast clinics under the “red flag” pathway across Northern Ireland, with waiting times stretching far beyond the 14-day target designed to ensure rapid assessment where breast cancer is suspected.